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Abstract
Background: This cross-sectional study assessed factors affecting access to antiretroviral therapy (ART) among HIV-
positive women from the prevention of mother to child transmission HIV programme in Chitungwiza, Zimbabwe.
Methods: Data were collected between June and August 2008. HIV-positive women attending antenatal clinics
who had been referred to the national ART programme from January 2006 until December 2007 were surveyed.
The questionnaire collected socio-demographic data, treatment-seeking behaviours, and positive or negative
factors that affect access to HIV care and treatment.
Results: Of the 147 HIV-positive women interviewed, 95 (65%) had registered with the ART programme. However,
documentation of the referral was noted in only 23 (16%) of cases. Of the 95 registered women, 35 (37%) were
receiving ART; 17 (18%) had not undergone CD4 testing. Multivariate analysis revealed that participants who
understood the referral process were three times more likely to access HIV care and treatment (OR = 3.21, 95% CI
1.89-11.65) and participants enrolled in an HIV support group were twice as likely to access care and treatment (OR
= 2.34, 95% CI 1.13-4.88). Those living with a male partner were 60% less likely to access care and treatment (OR =
0.40, 95% CI 0.16-0.99). Participants who accessed HIV care and treatment faced several challenges, including long
waiting times (46%), unreliable access to laboratory testing (35%) and high transport costs (12%). Of the 147 clients
surveyed, 52 (35%) women did not access HIV care and treatment. Barriers included perceived long queues (50%),
competing life priorities, such as seeking food or shelter (33%) and inadequate referral information (15%).
Conclusions: Despite many challenges, the majority of participants accessed HIV care. Development of referral
tools and decentralization of CD4 testing to clinics will improve access to ART. Psychosocial support can be a
successful entry point to encourage client referral to care and treatment programmes.
Background
Zimbabwe has one of the highest HIV infection rates in
the world [1-3]. In 2007, the HIV prevalence among
pregnant women attending antenatal clinics was around
15.6% [2,3]. Prevention of mother to child transmission
(PMTCT) of HIV is a major public health challenge in
Zimbabwe [4]. Linking PMTCT programmes with HIV
care and treatment is critical for promoting maternal
health and survival and to reduce paediatric HIV
infection [4]. Although scale up of antiretroviral therapy
(ART) is occurring in most countries in sub-Saharan
Africa, data indicate that less than 10% of HIV-infected
pregnant women in sub-Saharan Africa have access to
ART [5].
The Zimbabwe AIDS Prevention Project (ZAPP)-
Family AIDS Initiatives (FAI) supports the implementa-
tion of the national PMTCT programme at five antena-
tal sites in Chitungwiza. Since 2002, the ZAPP-FAI
programme has been funded by the Elizabeth Glaser
Pediatric AIDS Foundation (EGPAF) and United States
Agency for International Development (USAID) [3]. In
2004, the Government of Zimbabwe started to roll out
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including Chitungwiza [2].
In low-income countries, traditionally PMTCT and
HIV care and treatment programmes have been running
as parallel programmes with weak linkages [6]. Recent
studies from resource-limited settings have shown that
the majority of HIV-infected women and their partners
face considerable challenges in accessing care, treatment
and support services [7-12]. There is very limited
research on barriers to access HIV care and treatment
among HIV-positive pregnant women from the PMTCT
programme in sub-Saharan Africa [13,14]. To our
knowledge, there is no published literature on this topic
from Zimbabwe. The objective of this study was to
assess the factors affecting access to ART and HIV care
among HIV-positive women who participated in a
PMTCT programme in urban Zimbabwe.
Methods
Study design, setting and sample
Between June and August 2008, a cross-sectional study
of factors affecting access to ART and HIV care among
HIV-positive women from the PMTCT programme was
performed. The study was conducted at the four muni-
cipal antenatal clinics in Chitungwiza, a high-density
urban town in Zimbabwe with a population of 1.2 mil-
lion. Approximately 10,000 pregnant women book for
antenatal care annually in the Chitungwiza clinics.
A basic package of PMTCT services was provided at
the antenatal clinics, including training of healthcare
workers on PMTCT, routine antenatal HIV counselling
and testing ("opt-out” approach) for all pregnant women
using rapid HIV testing, administration of single-dose
mother/infant nevirapine (NVP) regimen, counselling
and support on infant feeding choices according to
World Health Organization (WHO) guidelines, estab-
lishment of community-based psychosocial support
groups, and mother-infant follow up until 18 months
after delivery [3]. Overall, the uptake of single-dose
mother/infant NVP uptake exceeds 90% in the clinics.
The study population included all HIV-positive
women from the PMTCT programme at the antenatal
clinics who were referred to the national ART pro-
gramme at the Chitungwiza Central Hospital from Janu-
ary 2006 until December 2007. The referral was made
based on symptomatic disease and/or clinic physician’s
assessment of mothers based on WHO clinical staging
during antenatal/post-partum follow-up visits. At the
antenatal clinics, CD4 cell count testing facilities were
unavailable at the time of data collection. During the
referral counselling sessions, peer counsellors (also
referred to as “community mobilizers”)i n f o r mt h ec l i -
ents regarding the registration process at the ART clinic
at the hospital.
Documentation of the referral between the PMTCT
programme at the antenatal clinic and the ART pro-
g r a m m ea tt h eh o s p i t a li sd o n eb yat w o - s t e pr e f e r r a l
form. After counselling, peer counsellors at the clinic
(referring end) complete the top part of the referral
form and document the referral made in a “registration
book” kept at the clinic. The clients then take the refer-
ral form to the ART clinic at the hospital (receiving
end). During registration, the healthcare worker in the
ART clinic completes and retains the bottom part of the
referral form in a folder, while the top part of the refer-
ral form is returned to the client to take back to the
PMTCT clinic for review by the clinic physician/peer
counsellors, who then document the completed referral
in the registration book.
Recruitment procedures
The clinic offers a unique mentorship programme led by
peer counsellors ("community mobilizers”). HIV-infected
women who had had previously participated in a
PMTCT programme at our site, were currently enrolled
in support groups, and had disclosed their positive HIV
status to partners or family members were selected to
become peer counsellors [3]. The peer counsellors are
assigned to the antenatal and postnatal clinics and
trained to deliver health education talks to antenatal
women, provide psychosocial support and counsel
mothers on disclosure and infant feeding, facilitate
mother-infant follow up, and engage in community
mobilization. The peer counsellors also conduct home
visits in the community if the clients fail to show up for
their appointments.
Study participants were identified and recruited for
interviews by peer counsellors at postnatal clinics,
PMTCT support group meetings and the infant follow-
up clinic. HIV-positive women who were participating
in other ongoing research studies at the clinics that
facilitated transportation and registration at the ART
clinic were excluded from this study. Clients who came
for ANC bookings while they were already on ART
were also excluded, as were male partners and HIV-
infected infants and children referred for care and treat-
ment services.
Data collection
After informed consent, a pre-tested structured ques-
tionnaire was administered to all eligible participants in
the local language, Shona, by four trained bilingual
research assistants. The interviews were conducted in a
private room in the clinic and lasted for approximately
45 minutes. Clients who did not follow up to attend
clinic-based PMTCT activities within the first four
weeks of study were visited at their homes by peer
counsellors and invited to come to the clinic to
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the mothers to participate in the interviews.
Development of study measure
Two focus group discussions (FGDs) were conducted
with groups of 10 to 12 clients from the PMTCT pro-
gramme at the Highfield polyclinic in Harare and key
informants in the antenatal clinic to explore the factors
associated with accessing HIV care and treatment and
develop the study questionnaire. The Highfield clinic is
located in the capital city of Harare, which has a similar
demographic and socioeconomic status to Chitungwiza.
The FGDs identified themes to be included during the
interviews with clients. They also ensured that the lan-
guage and phraseology used on the questionnaire and
consent forms were appropriate and interpreted cor-
rectly by the community. A pre-set discussion guide was
used during the FGDs, with one of the authors (AM)
serving as a facilitator. The discussions were conducted
in the local language of the group, taped, translated and
transcribed by the facilitator for analysis. The narratives
f r o mt h eF G D sw e r ea n a l y z e du s i n gat w o - s t a g et h e -
matic analysis. The data generated from the FGDs were
used to develop the study questionnaire.
The study questionnaire
From the FGDs, a structured questionnaire, which had
both open-ended and closed-ended questions, was
developed. The questionnaire collected socio-demo-
graphic data, treatment-seeking behaviours, and positive
or negative factors that affect access to HIV care and
treatment. In this study “access to HIV care and treat-
ment” was defined as successful completion of registra-
tion at the ART clinic. The questionnaire was reviewed
for both the content and structure by all the authors. It
was then translated into Shona and then back into Eng-
lish by a local bilingual translator to be sure the
intended meaning was conveyed.
Ethical considerations
This study was approved by the Medical Research
Council of Zimbabwe and the Institutional Review
Board at Wake Forest University Health Sciences. Ethi-
cal approval was also obtained from the Chitungwiza
Health Department and the Zimbabwe Ministry of
Health and Child Welfare. Informed consent was
obtained from all participants.
Statistical analysis
Data was entered using the Epi Info 2002 version 3.2.3
(Centers for Disease Control and Prevention, Atlanta,
GA) and analyzed using STATA version 10 (STATA
Corp, College Station, TX, USA). Continuous variables
were summarized using medians (interquartile range)
and categorical variables using proportions. Groups
were compared for differences using the Chi-square test
for categorical variables and Mann-Whitney U test for
continuous variables. Logistic regression was used to
identify the barriers and enhancers of access to HIV
care among HIV-infected women. All variables that
yielded a p-value of <0.2 in the univariate analysis were
tested in the multivariate model. The results of the
logistic regression analyses are depicted as odds ratio
(ORs) and their corresponding 95% confidence intervals
(CIs). We considered an association to be statistically
significant if p ≤0.05.
Results
A total of 246 HIV-infected women from the PMTCT
programme were referred to the ART programme at the
Chitungwiza Central Hospital between January 2006 and
December 2007. Figure 1 shows the study profile. The
majority of the participants (66%) were recruited by
peer counsellors at the postnatal clinic, followed by sup-
port group meetings (25%), the infant follow-up clinic
(7%) and at home (3%). None of the eligible participants
refused to participate.
Of the 246 participants referred, 45 (19%) women
were excluded from the study because they were partici-
pating in a US National Institutes of Health-funded clin-
ical trial, which facilitated transportation and
registration of clients at the ART programme. Of the
201 eligible participants, 46 (23%) were lost to follow
up, while eight (4%) had deceased by the time of the
interviews. Of the 46 clients who were lost to follow up,
41 (20%) had moved out of the study area, while five
(10%) had relocated to other countries in the region.
Of the 147 participants who were interviewed and eli-
gible for inclusion in this survey, 95 (65%) had regis-
tered with the ART programme, while 52 (35%) had not
registered. However, on review of the registration book
at the antenatal clinic, documentation of the referral
between the PMTCT programme and the ART clinic
was noted in 23 (16%) of cases.
Socio-demographic characteristics
Table 1 summarizes the socio-demographic characteris-
tics of the study participants. There were no significant
differences in the demographic characteristics of the
participants who accessed HIV care and those who did
not access care. The mean age of the participants who
accessed care and treatment was 30.1 ± 5.1 years com-
pared with the mean age of 29.1 ± 5.1 years among
those who did not access care and treatment. The
majority of the participants were married (78%), had
attained secondary education (83%) and were self-
employed (58%). The main source of household income
was the male partner (57%). More than a third of the
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(a unique religious sect in Zimbabwe, which does not
believe in modern medicine). The majority (66%) of the
participants lived within walking distance to Chitung-
wiza Central Hospital, where the ART clinic is located,
whereas 27% of the participants used public transport to
get to the ART clinic.
Access to HIV care
Of the 147 participants interviewed, 95 (65%) had regis-
tered with the ART clinic. Of the 95 women who had
registered, 35 (37%) participants had been initiated on
ART; 17 (18%) had not undergone CD4 count testing;
eight (8%) had CD4 counts of <350 cells/mm
3 but were
not receiving ART, while 35 (37%) had CD4 counts of
Total clients referred from the 
PMTCT programme
n=246
Total population eligible 
for study
n=201 (81%)
Excluded n=45
Enrolled in other 
research studies=42,
(17%); males=3 (2%)
Total followed up
n=155 (77%) 
Lost to follow up
n=46 (23%) 
Total women interviewed
n=147 (95%) 
Deceased
n=8 (5%)
Accessed HIV care
n=95 (65%)
Accessed within 
3 months
n=21 (22%) 
Did not access HIV care
n=52 (35%)
Accessed after 
3 months
n=74 (78%) 
Figure 1 Study profile.
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3 and were monitored every six months
for eligibility of ART. Of the 95 participants who were
successfully registered with the ART programme, 21
(22%) made the first visit to the ART clinic after three
months of being referred (median of 21 days Q1 = 7
days, Q3 = 120).
Challenges faced by participants who accessed HIV care
and treatment
Table 2 shows the challenges perceived by study partici-
pants who accessed HIV care and treatment services
(n = 95). Participants who accessed HIV care and treat-
ment faced several challenges, including: long waiting
times at the ART clinic (46%); unreliable access to
laboratory tests, such as CD4 count, complete blood
counts and liver function tests (35%); and high transport
costs (12%). The median duration of time spent by the
participants at each visit to the ART clinic was reported
to have been five hours (Q1 = 1 hour, Q4 = 10 hours).
The interviewer asked the participants to report the
duration of every single clinic visit that they had made,
and then the median was calculated from the total of all
visits made by all women.
Challenges faced by participants who did not access HIV
care and treatment
Of the 147 clients surveyed, 52 (35%) women did not
access HIV care and treatment. As shown in Table 3,
reasons cited by women who did not access HIV care
Table 1 Demographic characteristics of participants
(N = 147)
Characteristics Total
number
Accessed
HIV care
Accessed
HIV care (%)
Marital status
Married 114 70 61
Widowed 18 14 78
Divorced 11 8 73
Single 4 3 75
Educational level
Secondary 122 82 67
Primary 23 11 48
Tertiary 2 2 100
Employment status
Self-employed 85 55 65
Unemployed 54 33 61
Formally employed 8 7 87
Religion
Apostolic 51 34 67
Pentecostal 32 21 66
Catholic 22 17 77
Methodist 13 7 54
Anglican 10 5 50
Seventh Day Adventist 7 5 71
Other 12 6 50
Source of income
Husband 83 53 64
Self 48 33 69
Parents 4 2 50
Others 12 7 58
Transport to ART clinic
Walking 97 66 68
Public transport 40 22 55
Walk or public transport 9 7 78
Own transport 1 0 0
ART, antiretroviral therapy
Table 2 Challenges faced by HIV-positive women from
the PMTCT programme who accessed HIV care and
treatment services (n = 95)
Challenges Frequency
(%)
Long queues at the ART clinic 44 (46.3)
Constant breakdown of laboratory equipment 33 (34.7)
ART clinic too congested with very sick people 16 (16.8)
Transport for repeat visits too high 11 (11.6)
Service too slow, maybe due to staff shortages 8 (8.4)
Shortage of antiretroviral drugs 5 (5.2)
Registration process too long 5 (5.2)
Hospital administration fees unaffordable 4 (3.8)
Loss of confidentiality 3 (3.2)
Stigmatization by health workers 3 (3.2)
Fear that child may get opportunist infections at the
ART clinic
2 (2.1)
*This was a multiple response question and hence the percentages adds up
to more than 100%
ART, antiretroviral therapy; PMTCT, prevention of mother to child transmission
of HIV
Table 3 Reasons cited by HIV-positive women for not
accessing HIV care and treatment services (n = 52)
Reasons Frequency (%)
Perceived long queues/laborious registration process 26 (50)
Competing priorities 17 (32.7)
Inadequate referral information 8 (15.4)
High transport costs 7 (13.5)
Procrastination 4 (7.7)
Lost referral letter 3 (5.8)
Lack of disclosure 2 (3.8)
Did not believe the results 2 (3.8)
Fear loss of confidentiality 2 (3.8)
Fear side effects 1 (1.9)
High hospital fees 1 (1.9)
*This was a multiple response question and hence the percentages adds up
to more than 100%
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registration process and/or long queues (50%), compet-
ing life priorities (33%) (e.g., seeking food or shelter, car-
ing for other children in the home and caring for sick
relatives), and inadequate referral information (15%).
Factors associated with access to HIV care and treatment
In the univariate analysis (Table 4), understanding the
referral process was significantly associated with access
to HIV care and treatment (OR = 3.09, CI 2.07-14.89),
with those participants who understood the referral pro-
cess being three times more likely to access HIV care
and treatment than those who did not understand the
referral process. Participants who were members of a
HIV support group were twice as likely to access HIV
care and treatment as those who did not belong to any
HIV support group (OR = 2.39, CI 1.13-5.12).
Multivariate analysis (Table 5) revealed that access to
HIV care and treatment were significantly associated
with participants who understood the referral process
(OR = 3.21, CI 1.89-11.65) and those enrolled in an
HIV support group (OR = 2.34, CI 1.13-4.88). Those liv-
ing with a male partner were 60% less likely to access
care and treatment (OR = 0.40, CI 0.16-0.99).
Discussion
Very few studies from sub-Saharan Africa countries
have described barriers to access care and treatment
among HIV-positive pregnant women from the PMTCT
programme [13,14]. This study is among the first to
assess the factors affecting access to ART and HIV care
among PMTCT women in Zimbabwe. We found that
two-thirds of all PMTCT clients referred to the ART
clinic at Chitungwiza Central Hospital between January
2006 and December 2007 accessed HIV care. However,
documentation of the referral system between the
PMTCT programme at the antenatal clinic and the
ART programme at the hospital was poor (noted in
only 16% of cases). The severe shortage of healthcare
workers due to staff attrition at the ART clinic may
have contributed to this finding. Development of referral
Table 4 Univariate analyses for factors associated with
access to HIV care and treatment among HIV-positive
women from the PMTCT programme
Predictors Unadjusted odds ratio 95% CI
Understood the referral process
No 1
Yes 3.09 2.07-14.89
Joined any support group
No 1
Yes 2.39 1.13-5.12
Ever been stigmatized
No 1
Yes 1.90 0.59-6.20
Believed/accepted HIV status
No 1
Yes 1.85 0.89-3.82
Ready to be referred to ART clinic
No 1
Yes 1.81 0.71-4.62
Number of children who died
None 1
At least one 1.40 0.48-2.05
Witnessed someone being stigmatized
No 1
Yes 1.38 0.65-2.93
Feeling after being referred
Negative 1
Positive/good 1.25 0.20-7.74
Educational level
Secondary/tertiary 1
Primary 0.44 0.17-1.12
Living with male partner
No 1
Yes 0.46 0.19-1.99
Age group
>=3 5 1
<35 0.57 0.19-1.66
PMTCT knowledge levels
> = 51% 1
<51% 0.58 0.29-1.15
Herbal treatments for HIV infection
No 1
Yes 0.67 0.34-1.34
Transport to ART clinic
Walk 1
Public transport 0.69 0.32-1.49
Household income
Self 1
Table 4: Univariate analyses for factors associated with
access to HIV care and treatment among HIV-positive
women from the PMTCT programme (Continued)
Partner 0.76 0.36-1.61
Employment status
Employed 1
Unemployed 0.795 0.40-1.59
ART, antiretroviral therapy; PMTCT, prevention of mother to child transmission
of HIV
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the follow-up system could facilitate the link between
PMTCT and ART programmes. The implementation of
simple referral system using referral forms has been
effective in linking diagnosed patients with ART clinics
in rural Tanzania [15].
In the present study, even though 65% of HIV-infected
w o m e nf r o mt h eP M T C Tp r o g r a m m eh a dr e g i s t e r e da t
the ART clinic, only 37% were receiving ART. The
majority of PMTCT clients were at various stages in the
process of accessing HIV care and treatment; 18% of
registered women had not had their CD4 tested and 8%
of participants with CD4 counts of <350 cells/mm
3 were
not receiving ART. This finding is consistent with other
reports from sub-Saharan Africa [5,7,8,10,12].
In our study, 22% of participants reported a delay of
more than three months after a referral was made in
accessing HIV care despite the fact that most of the cli-
ents were within walking distance of the ART clinic.
This finding is of great concern since timely access to
ART is critical for HIV-infected pregnant women with
symptomatic disease to reduce the risk of mother to
child transmission of HIV and promote maternal health
and survival [16]. In addition, access to ART by post-
partum mothers can reduce the risk of HIV transmis-
sion during the breastfeeding period [17].
Many challenges were reported by study participants
who accessed HIV care and treatment services at the
ART clinic. Nearly half of participants experienced long
waiting times at the clinic. Waiting times is an impor-
tant factor for patient dissatisfaction while accessing
HIV care and treatment services [10,18]. In one study
from Uganda, innovative organizational changes, includ-
ing nurse visits and pharmacy-only refill visits, have
been successful in significantly decreasing the waiting
times at the clinic [19]. Other challenges cited include
unreliable access to laboratory diagnostics, e.g., CD4
testing, and overcrowding at the ART clinics. Similar
findings have been reported from Mozambique and
Zambia [10,12].
In the Chitungwiza urban setting, most (66%) of the
participants could walk to the ART clinic from their
homes. In contrast, the long distance from the home to
the ART clinic has been cited as a major barrier in
many other settings in sub-Saharan Africa [10,17,20-22].
In rural settings, transport costs could be a major factor
affecting access to HIV care [21,23]. Decentralization of
HIV care and treatment services, including CD4 count
testing, to clinic level will improve access to ART in our
setting.
In this study, several barriers were reported by partici-
pants who did not access HIV care and treatment at the
clinic. One-third of participants reported competing life
priorities, such as earning livelihoods and seeking food
and shelter, as major barriers to accessing HIV care.
This finding is not surprising given the current eco-
nomic crisis in Zimbabwe [24]. In contrast to other stu-
dies [25-27], stigma associated with HIV/AIDS did not
discourage the study participants from accessing HIV
care. More than two-thirds of the study participants
were members of a PMTCT psychosocial support
group, which may have promoted positive health-seek-
ing treatment behaviours and effective strategies to cope
with HIV-related stigma [28]. In this study, participants
who were members of an HIV support group were
twice as likely to access HIV care and treatment services
as those that were not members of a support group.
This study also identified health system barriers facing
participants who did access HIV care and treatment ser-
vices. Perceived long queues at the clinic were reported
as a major barrier by 50% of these participants. Inade-
quate referral information was reported by 15% of parti-
cipants who did not access HIV care. Similar health
system barriers have been reported in other studies con-
ducted in developing countries [25,29]. Participants who
reported that they had understood the referral process
were three times more likely to access HIV care than
those who did not access care.
It is recommended that information, education and
communication materials should be developed to
strengthen understanding of the referral systems. During
the referral counselling sessions, peer counsellors can
Table 5 Multivariate analyses for factors associated with
access to HIV care and treatment among HIV-positive
women from the PMTCT programme
Predictors Adjusted odds ratio 95% CI
Understood referral process
No 1
Yes 3.21 1.89-11.65
Joined any support group
No 1
Yes 2.34 1.13-4.88
Living with male partner
No 1
Yes 0.40 0.16-0.99
Educational level
Secondary/tertiary 1
Primary 0.47 0.17-1.28
Knowledge level of PMTCT
≥51% 1
<51% 0.53 0.25-1.12
Believed/accepted HIV status
No 1
Yes 1.97 0.90-4.32
PMTCT, prevention of mother to child transmission of HIV
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the ART clinic using these materials. Given the low pro-
portion of referrals that were documented in this study,
it is also likely that healthcare workers were not able to
accurately explain the referral process to the clients.
Therefore, training and ongoing supervision of health
workers is recommended. This is particularly important
in our setting given the high staff attrition rates due to
economic instability [24].
This study has several limitations. First, 23% of the
participants were lost to follow up due to the mobility
of the population in the city of Chitungwiza. Second,
participants were not asked to rank barriers based on
their relative importance. This makes it difficult to con-
clude which of the barriers identified was the most chal-
lenging to overcome. Third, this study was conducted in
an urban setting and our study results may not poten-
tially be generalized to rural settings. Finally, our study
relied on self-report with a potential for reporting bias.
Despite these limitations, our study provides significant
insights into factors that affect access to HIV care and
treatment and informs policy makers to find ways to
address these barriers and encourage individuals to
access treatment.
Conclusions
D e s p i t em a n yc h a l l e n g e s ,t h em a j o r i t yo fw o m e n
accessed HIV care following a referral from the PMTCT
programme. Development of referral tools and decentra-
lization of CD4 count testing and ART initiation within
maternal and child health units may improve access to
ART. In addition, psychosocial support can be a suc-
cessful entry point to encourage referrals into care and
treatment programmes.
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